Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
02/28/1996 | EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent |
02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
02/28/1996 | CN1117735A Steroids for treating menopausal complaints |
02/27/1996 | US5494907 11-β substituted-19-nor steroids |
02/27/1996 | US5494906 Treating metabolic bone disease |
02/22/1996 | WO1996005164A1 Anti-inflammatory preparation |
02/22/1996 | CA2196422A1 Anti-inflammatory preparation |
02/21/1996 | EP0697408A1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists |
02/21/1996 | EP0588797B1 N- 4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections |
02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
02/21/1996 | CN1116940A Medicinal composite for rheumatism |
02/20/1996 | US5492922 Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation |
02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
02/15/1996 | WO1996003999A1 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
02/15/1996 | WO1996003983A1 Inhibition of leukotriene biosynthesis with urea derivatives |
02/15/1996 | CA2196701A1 Inhibition of leukotriene biosynthesis with urea derivatives |
02/14/1996 | CN1116628A Cyclopeptides of the formulal |
02/14/1996 | CN1116529A Method for preparing "Jingluotong" medicine for clearing and activating channels and collaterals |
02/13/1996 | CA2035841C Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture |
02/08/1996 | WO1996003385A1 3,4-substituted pyrazoles for the treatment of inflammation |
02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
02/08/1996 | CA2195123A1 3,4-substituted pyrazoles for the treatment of inflammation |
02/01/1996 | WO1996002565A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
02/01/1996 | WO1996002507A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
02/01/1996 | WO1996002259A1 Hard tissue stimulating agent |
02/01/1996 | CA2195474A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
02/01/1996 | CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
01/31/1996 | EP0694561A1 Calcitonin analogue and use thereof |
01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
01/30/1996 | US5488058 Urogenital disorders or osteoporosis |
01/25/1996 | WO1996001825A1 Heterobicyclic derivatives |
01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
01/24/1996 | EP0693285A2 Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss |
01/24/1996 | EP0692965A1 Method and composition for treatment of osteoporosis |
01/24/1996 | EP0451216B1 Humanized immunoglobulins and their production and use |
01/24/1996 | CN1115240A Pill for stimulating circulation of blood and causing muscles and joints to relax |
01/23/1996 | US5486534 3,4-substituted pyrazoles for the treatment of inflammation |
01/23/1996 | CA2154414A1 Combination treatment for inhibiting bone loss |
01/23/1996 | CA2154403A1 A novel osteoblast proliferative factor |
01/23/1996 | CA1337972C Agent for treating hyperuricemia |
01/17/1996 | EP0691849A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
01/17/1996 | EP0691814A1 Method and composition for treatment of osteoporosis |
01/17/1996 | EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
01/17/1996 | CN1114886A Bones and tendon recovery cream |
01/16/1996 | US5484891 Pure polypeptide able to hybridize under low stringency conditions; glycoproteins |
01/16/1996 | US5484797 Naphthly compounds, intermediates, processes, compositions, and method for inhibiting endometrosis |
01/16/1996 | US5484796 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting aortal smooth muscle cell proliferation |
01/16/1996 | US5484795 Naphthyl compounds, intermediates, processes, compositions, and method of inhibiting restenosis |
01/11/1996 | WO1996000730A1 Vitronectin receptor antagonists |
01/11/1996 | WO1996000574A1 Vitronectin receptor antagonists |
01/11/1996 | CA2193966A1 Vitronectin receptor antagonists |
01/10/1996 | EP0691129A2 Thiazolidone and pyrrolidinone compounds for inhibiting bone loss |
01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
01/10/1996 | EP0690871A1 Growth differentiation factor-5 |
01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
01/09/1996 | CA2074639C Pharmaceutical composition suitable for influencing the reticuloendothelic system and for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or accompanying diseases of tumorous origin, a process for preparing same and its use |
01/07/1996 | CA2153213A1 Methods of inhibiting bone loss |
01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
01/03/1996 | EP0689544A1 Process for production of an imidazole derivative |
01/03/1996 | CN1030609C Methylenebisphosphonic acid derivatives |
01/02/1996 | US5480873 Arthritis |
12/27/1995 | EP0688787A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
12/27/1995 | EP0688360A1 Bone stimulating factor |
12/27/1995 | EP0688214A1 Methods for inhibiting bone loss with 3,4-diarylchroman |
12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
12/26/1995 | US5478955 26,27-dimethylene-1α,25-dihydroxyvitamin D2 and 26, 27-dimethylene-24-epi-1α, 25-dihydroxyvitamin D2 and methods for preparing same |
12/26/1995 | US5478847 Methods of use for inhibiting bone loss and lowering serum cholesterol |
12/20/1995 | EP0687470A2 Agents for treating metabolic bone diseases |
12/20/1995 | EP0687270A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
12/19/1995 | US5476866 Isoxazoles |
12/19/1995 | US5476865 Methods of inhibiting bone loss |
12/18/1995 | CA2152023A1 Agents for treating metabolic bone diseases |
12/14/1995 | WO1995033830A1 Bmp-9 compositions |
12/14/1995 | WO1995033763A1 Novel elastase inhibitors |
12/14/1995 | WO1995033762A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
12/14/1995 | WO1995033466A1 Pyridylbisphosphonates for use as a therapeutical agent |
12/13/1995 | EP0686037A1 Hormone replacement therapy |
12/12/1995 | US5474995 Phenyl heterocycles as cox-2 inhibitors |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/07/1995 | WO1995032710A1 Compounds for inhibiting osteoclast-mediated bone resorption |
12/07/1995 | WO1995032623A1 Meniscal augmentation device |
12/07/1995 | CA2190870A1 Compounds for inhibiting osteoclast-mediated bone resorption |
12/06/1995 | EP0684827A1 USE OF 26,26,26,27,27,27-HEXAFLUORO-1$g(a),25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS |
11/29/1995 | EP0684241A1 N-pyridyl carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them |
11/29/1995 | EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution |
11/29/1995 | CN1112421A Estradiol weekly-acting percutaneous absorption adhesive plaster |
11/29/1995 | CN1112420A Orally administerable pharmaceutical formulations |
11/28/1995 | US5470952 Interleukin antagonists |
11/23/1995 | WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE |
11/23/1995 | WO1995031203A1 Oral liquid alendronate formulations |
11/22/1995 | EP0683173A1 Cyclic adhesion inhibitors |
11/22/1995 | EP0683156A1 Acylated aminoalkanimidazoles and -triazoles |
11/22/1995 | EP0682672A1 Steroids for treating menopausal complaints |
11/22/1995 | CN1112104A Acetic acid derivatives |